Approval is the first by an international regulator allowing the marketing of a precisely dosed cannabis inhaler as a medical product, Syqe® Medical says.
‘The Whole World Is In Overdose,’ Says CEO Of SyqeAir About the Groundbreaking Cannabis Inhaler
An article on Benzinga highlighting the innovative SyqeAir Inhaler and its role in addressing the global challenge of cannabis overdose through metered dosing. Read what the CEO of SyqeAir, Hagit Kamin, had to say about this.